The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

HIGH PEAK, England & CAMBRIDGE, Mass. & HOUSTON--(BUSINESS WIRE)--UK-based biotechnology company Retrogenix and US-based Resonant Therapeutics, Inc. announced today that they have entered into a ...

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of the Retrogenix® Non-Human Protein Library. The non-human protein library helps biopharmaceutical ...

Manchester, UK and Cambridge, MA, 19th June 2014 – Biotechnology firm Retrogenix today announces the appointment of Matthew Britz as North American Business Development Director. Matthew will operate ...

WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has acquired Retrogenix Limited, an early-stage contract research organization ...

Staff at fast-growing biotech Retrogenix have this month received royal recognition for the development and commercialization of the company's proprietary plasma membrane protein array technology. The ...

The positions in the table below reflect the Retrogenix Ltd.'s position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to the ...

Retrogenix has announced that it has opened its first office in the United States - the fastest growing regional market for the UK-based biotech which provides drug target screening services to global ...

Charles River Laboratories International, Inc. CRL recently launched its latest Retrogenix Non-Human Protein Library. This non-human protein library will help biopharmaceutical clients assess ...

Biotechnology firm Retrogenix today announces the appointment of Matthew Britz as North American Business Development Director. Matthew will operate out of Retrogenix's offices in Cambridge, MA, and ...